AbbVie | ABBV - Stock

Stock Price
217.11
Daily Change
-8.55 -3.79%
Monthly
-1.39%
Yearly
13.23%
Q1 Forecast
216.14

AbbVie reported $4.94B in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.94B 22M Sep/2025
Abbott USD 6.71B 246M Sep/2025
ALKERMES USD 191M 927K Sep/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Biogen USD 2.21B 64.9M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eisai JPY 227.32B 11.41B Jun/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
J&J USD 14.15B 734M Sep/2025
Medtronic USD 6.16B 270M Sep/2025
Merck USD 6.44B 157M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pacira USD 157.68M 9.52M Sep/2025
Perrigo USD 1.23B 11.5M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025
Zoetis USD 2.47B 26M Sep/2025